Zhen Su, CEO and Entrepreneur at Marengo Therapeutics, shared a post on LinkedIn:
“The future of oncology will not be built by iteration alone.
I’m honored to join fellow leaders for ‘Beyond ‘Next-gen’: How Should We Engineer Future Breakthroughs?’ to discuss what it will take to unlock the next era of innovation in oncology – from novel targets and new therapeutic paradigms to unconventional approaches in targeted therapy and immuno-oncology.
The next breakthroughs will come not from asking how to make existing models incrementally better, but from asking bold questions about how we engage with cancer biology itself.
Looking forward to sharing the stage with Dennis Chang, Alicia Zhou, Axel Hoos, and Joe Guidi for this important conversation.”
Other Articles Featuring Zhen Su on OncoDaily.